Last Updated: 11/07/2024

Identification of Compounds Targeting Specifically Plasmodium malariae Malaria for its Elimination Along with Plasmodium falciparum

Objectives

To identify approved anti-malarial drugs that are effective also against the neglected malaria-causing pathogen Plasmodium malariae, which has become widespread in sub-Saharan Africa.

Principal Investigators / Focal Persons

Laurent Dembele

Partner Institutions

University of Ghana (UG), Ghana

Partner Investigators

Yaw Aniweh

Rationale and Abstract

To eliminate malaria, treatments should be effective for all circulating malaria pathogens. However, current artemisinin-based combination therapies (ACTs) are largely designed to target the historically more prevalent P. falciparum species. They will recruit around 400 patients with uncomplicated malaria in Faladje to determine the P. malariae malaria burden. They will also evaluate the ability of a panel of anti-malarial compounds to destroy cultured P. malariae together with P. falciparum to help guide treatment strategies.

Thematic Categories

Drug-based Strategies

Date

Jul 2021 — May 2023

Total Project Funding

$100,000

Funding Details
Bill & Melinda Gates Foundation (BMGF), United States

Grand Challenges Africa. Grand Challenges Africa: Drug Discovery
Project Site

Mali

SHARE

Related Resources

No related items found

Related Projects

No related items found

SHARE